{{Rsnum
|rsid=1884679
|Gene=SLC24A4
|Chromosome=14
|position=92377218
|Orientation=minus
|GMAF=0.4307
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Gene_s=SLC24A4
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 18.0 | 44.1 | 37.8
| HCB | 6.6 | 32.1 | 61.3
| JPT | 2.7 | 31.9 | 65.5
| YRI | 34.0 | 48.3 | 17.7
| ASW | 33.3 | 45.6 | 21.1
| CHB | 6.6 | 32.1 | 61.3
| CHD | 6.4 | 31.2 | 62.4
| GIH | 9.9 | 40.6 | 49.5
| LWK | 35.5 | 50.0 | 14.5
| MEX | 19.0 | 46.6 | 34.5
| MKK | 33.3 | 50.0 | 16.7
| TSI | 22.5 | 48.0 | 29.4
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs1884679
|Name_s=
|Gene_s=SLC24A4
|Feature=
|Evidence=PubMed ID:17537913
|Annotation=Risk or phenotype-associated allele: not stated Phenotype: Using a Quantitative Transmission Disequilibrium Test (QTDT), this variant was significantly associated with etoposide toxicity based upon IC50 values in cell lines from 30 parent-child trios. Study size: 87. Study population/ethnicity: 87 European descent Caucasians. Significance metric(s): p = 0.00001. Type of association: FA; GN.
|Drugs=etoposide
|Drug Classes=
|Diseases=Drug Toxicity
|Curation Level=Curated
|PharmGKB Accession ID=PA165109460
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1884679
|overall_frequency_n=63
|overall_frequency_d=128
|overall_frequency=0.492188
|n_genomes=40
|n_genomes_annotated=0
|n_haplomes=60
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}